Trials / Completed
CompletedNCT02439411
Retrospective Analysis of Dabrafenib +/- Trametinib Compassionate Use Experience in Spain
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 135 (actual)
- Sponsor
- Grupo Español Multidisciplinar de Melanoma · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to analyze whether Dabrafenib +/- Trametinib are effective in overall survival, response rates and toxicity in both programs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Trametinib |
Timeline
- Start date
- 2015-03-03
- Primary completion
- 2016-09-01
- Completion
- 2016-09-01
- First posted
- 2015-05-08
- Last updated
- 2019-12-02
Locations
29 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT02439411. Inclusion in this directory is not an endorsement.